Backgrounds/Aims: This study aims to evaluate the comparative effectiveness of two surgical approaches on the treatment outcomes of radiofrequency ablation (RFA) for malignant liver tumors. Methods: Fifty-seven patients with malignant liver tumors, hepatocellular carcinoma, cholangiocarcinoma and liver metastases, who were candidates for RFA, underwent laparoscopic or open surgical treatments. Results: The patients' characteristics were comparable in the two groups that received open (n=33, 57.9%) and laparoscopic (n=24, 42.1%) surgical treatments. There were no statistically significant differences between the two groups in terms of recurrence rate (p=0.337) and overall survival (p=0.423). However, patients in the laparoscopic RFA group had significantly shorter hospital stay (14.1 vs. 5.9 days, p＜0.05) and experienced fewer complications (Grade I: 62.5% vs. 26.3%, p=0.102 
INTRODUCTION
Hepatic resection remains the golden standard for treatment of patients with primary and metastatic liver malignancy. 1, 2 As one of the local ablative techniques available, radiofrequency ablation (RFA) is currently used for treating resectable small hepatocellular carcinoma (HCC). 3 Although the effectiveness is less well established, RFA has been widely accepted for treating patients with malignant liver tumors unsuitable for hepatectomy. 4, 5 Despite its advantages, minimal invasiveness and safety of use, there are some limitations. 6 RFA could damage adjacent visceral organs when tumors are located peripherally.
Especially, percutaneous RFA can cause pneumothorax or damage to the diaphragm when tumors are located near the dome of the liver. Also, multiple liver lesions limit RFA outcomes. 7, 8 To overcome these limitations, intraoperative RFA can be used as an alternative. 9, 10 The use of a laparoscopic or open approach allows placement of RFA electrodes at difficult locations with more accuracy under real time imaging guidance and multiple sites. 11 In previous studies, intraoperative RFA was shown to be a safe and effective treatment for HCC in difficult locations. 12, 13 However, there is a lack of studies comparing the efficacy of both intraoperative methods. This study aims to evaluate the comparative effectiveness of the two intraoperative approaches on the treatment outcomes of RFA for malignant liver tumors.
MATERIALS AND METHODS
From December 2008 to July 2013, we performed intraoperative RFA on 57 patients with malignant liver tumors.
The Cool-tip TM (18 Gauge) Radiofrequency Ablation System and the Evident TM Microwave Ablation System (Covidien, CO, USA). were used for RFA procedures. Intraoperative ultrasound examination and radiofrequency electrode insertion into the center of the tumor were performed by an experienced operator. The median time for the radio- All analyses were performed using the statistical software SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA).
Comparisons between the two groups were done using the Student t-test for continuous data and the x 2 test for categorical data. The overall and disease-free survivals were calculated using the Kaplan-Meier method. The relative prognostic significance of the variables in predicting overall and disease-free survival was analyzed using multivariate Cox proportional hazards regression analysis.
Significant difference was considered when p＜0.05. 
RESULTS
The patient and tumor characteristics are summarized in Tables 1 and 2 . There were no significant differences in sex, age, operative method, size of tumor, complication, and whether the tumor location was in the subcapsular region or not. Open surgical RFA was mostly performed at the tumor location of the liver, segment 7 (11 vs. 2, p=0.026). The majority of patients with HCC were Child-Pugh class A (92.3%) ( Table 2 Although there were no significant differences between the two groups, the laparoscopic RFA group experienced a lower incidence of complications (62.5% vs. 26.3%, p=0.102). Table 5 ). The number of tumors was the only significant factor affecting 
DISCUSSION
Radiologists initially used percutaneous RFA as treatment for solid tumors. Surgeons started to use RFA as a surgical approach for patients with tumors at locations that are too difficult for percutaneous treatment.
14 Unlike percutaneous treatment, the surgical approach can ablate tumors which are located near major blood vessels or bile ducts and adjacent organs and structures.
Otherwise, for small HCC in locations too difficult to apply a percutaneous approach, intraoperative RFA can be an alternative option for deep-seated tumors. [15] [16] [17] Several studies show that intraoperative RFA (by laparoscopy or laparotomy) results in superior local control compared to percutaneous RFA with similar overall survival and complication rates. [18] [19] [20] To assess the success of RFA treatment, we must closely evaluate the outcome with incomplete treatment, local recurrence, survival rates and complication rates taken into account. 21 However, there is no consensus among experts on which surgical approach is more practical.
The rate of incomplete ablation was generally reported to be less than 10% on tumor-by-tumor analysis. In a meta-analysis study of local recurrence after hepatic RFA, the total recurrence rate was 14.9% (352 of 2369) for patients with HCC and 14.7% (112 of 763) for patients with colon cancer metastases. 19 In that analysis, significantly fewer local recurrences were observed for a surgical (versus percutaneous) approach, (p＜0.001) even for small tumors (≤3 cm). In our study, local recurrence rate was 7.0% for all-tumor pathologies. Of the four patients with local recurrence, three received open surgical RFA. Two of the three had liver metastasis and the other had cholangiocarcinoma. There was no local recurrence in patients with HCC in the two groups.
In a study of RFA for 235 patients with colorectal liver metastases, the overall survival rates at 3 years were 20.2%. 26 Also, the mean survival for patients with tumors ＜3 and ＞3 cm was 28 and 20 months, respectively. It was reported that the overall 3-year survival rates after laparoscopic RFA for 66 patients with HCC were 38%. In the study of RFA for 231 unresectable hepatic tumors, the median length of hospital stay was 5 days after celiotomy. 28 Also, in one of the other studies, after laparoscopic and open RFA, mean hospital stay was 1-3 days and 4-7 days, respectively. 29 In our study, except in the case of simultaneous operation, mean hospital stay was 5.0 (3-14 days) and 11.5 days (7-27 days) after laparoscopic and open RFA, respectively (p=0.02).
We think that the intraoperative approach enables accurate with a large incision. 30 The laparoscopic approach is used most often for a limited number of tumors, particularly if mobilization of the liver or bowel is necessary, as well as for patients undergoing concomitant laparoscopic liver resection or colorectal resection.
In conclusion, laparoscopic RFA can be performed for malignant liver tumors with lower morbidity rates, less invasiveness and expense compared to an open surgical approach.
